Veteran investor and operator with a focus on growth-stage companies, M&A and board-level performance improvement, Kevin Galvin leverages a blend of operational leadership and transaction experience to advise and scale technology and services businesses. He is known for driving revenue-focused transformations, structuring growth financings, and supporting CEO teams through exits and strategic partnerships. Market-facing profile suits roles in private equity, growth equity or corporate development and frequent participation on governance and advisory bodies.
Veteran investor and operator with a focus on growth-stage companies, M&A and board-level performance improvement, Kevin Galvin leverages a blend of operational leadership and transaction experience to advise and scale technology and services businesses. He is known for driving revenue-focused transformations, structuring growth financings, and supporting CEO teams through exits and strategic partnerships. Market-facing profile suits roles in private equity, growth equity or corporate development and frequent participation on governance and advisory bodies.
Prioritizes growth-stage technology and services companies where operational intervention and deal structuring can unlock revenue and valuation upside. Emphasizes active board-level partnership, KPI-driven commercial turnarounds, and structuring growth financings that align management incentives with exit or strategic-partner scenarios. Uses a transaction-minded, operator lens to underwrite opportunities—favoring repeatable revenue models, clear paths to margin expansion, and defensible customer relationships. Time horizon is variable but outcome-focused, blending mid-term value creation with disciplined downside protection via covenants, earn-outs, and staged capital deployment.
Prioritizes growth-stage technology and services companies where operational intervention and deal structuring can unlock revenue and valuation upside. Emphasizes active board-level partnership, KPI-driven commercial turnarounds, and structuring growth financings that align management incentives with exit or strategic-partner scenarios. Uses a transaction-minded, operator lens to underwrite opportunities—favoring repeatable revenue models, clear paths to margin expansion, and defensible customer relationships. Time horizon is variable but outcome-focused, blending mid-term value creation with disciplined downside protection via covenants, earn-outs, and staged capital deployment.
| Trades 890 | Longs Won 621/890 69% | Profit Factor 13.98 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $244,038.93 |
| Average Win $55,962.43 | Best Trade (Oct 15) $4.17M | Sharpe Ratio -11.75 |
| Average Loss -$9,240.13 | Worst Trade (Oct 14) -$271,495.99 | Z-Score 2.71 (99.33%) |
| Commissions $0 | Avg. Trade Length 10m 2w 2d | Expectancy $36,255.14 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 18,868 | 16,981 | 15,094 | 13,208 | 11,321 | 9,434 | 7,547 | 5,660 | 3,774 | 1,887 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 7,229 | $1.79M | $2.48M | - | $681,441.2 | 37.98% | -0.137% |
ABBV AbbVie Inc. | 1,661 | $295,160.36 | $473,002.97 | - | $177,842.61 | 60.25% | +0.455% |
ABT Abbott Laboratories | 2,819 | $322,565.81 | $295,290.25 | - | -$27,275.56 | -8.46% | +1.729% |
ACWX ISHARES MSCI ACWI EX U.S. ETF | 138,864 | $9.63M | $10.34M | - | $716,759.97 | 7.45% | +0.202% |
AMGN Amgen Inc. | 1,729 | $455,388.65 | $759,273.06 | - | $303,884.41 | 66.73% | +3.058% |
AMZN Amazon.com Inc | 2,811 | $608,662.78 | $714,654.58 | - | $105,991.8 | 17.41% | +0.061% |
AON Aon plc | 745 | $265,239.76 | $213,710.7 | - | -$51,529.06 | -19.43% | +4.18% |
AUB Atlantic Union Bankshares Corporation | 11,231 | $351,305.72 | $426,890.31 | - | $75,584.59 | 21.52% | +1.495% |
AVGO Broadcom Inc. | 532 | $200,963 | $181,044.92 | - | -$19,918.08 | -9.91% | -1.716% |
AXP American Express Company | 852 | $252,865.56 | $267,400.2 | - | $14,534.64 | 5.75% | +2.248% |
BKNG Booking Holdings Inc. | 1,351 | $267,081.53 | $225,617 | - | -$41,464.53 | -15.53% | +3.933% |
BND Vanguard Total Bond Market Index Fund | 7,635 | $549,093.47 | $540,787.05 | - | -$8,306.42 | -1.51% | +0.611% |
BSV Vanguard Short-Term Bond ETF | 144,402 | $11.37M | $11.06M | - | -$313,437.92 | -2.76% | +0.229% |
BX Blackstone Inc. | 1,890 | $325,889.24 | $207,049.5 | - | -$118,839.74 | -36.47% | +3.145% |
CAT Caterpillar Inc. | 315 | $114,264.88 | $229,975.2 | - | $115,710.32 | 101.26% | -2.523% |
CGDV Capital Group Dividend Value ETF | 47,609 | $2.05M | $2.35M | - | $293,533.93 | 14.29% | +0.326% |
CGGR Capital Group Growth ETF | 95,742 | $3.63M | $4.56M | - | $922,359.57 | 25.39% | +0.486% |
CGXU Capital Group International Focus Equity ETF | 622,577 | $16.07M | $20.57M | - | $4.49M | 27.96% | +0.197% |
CL Colgate-Palmolive Company | 3,270 | $297,276 | $301,673.85 | - | $4,397.85 | 1.48% | -0.566% |
COST Costco Wholesale Corporation | 445 | $408,181.87 | $438,249.35 | - | $30,067.48 | 7.37% | +0.288% |